4^th Annual Dementia Congress November 26-27, 2024 Paris, France

This session track delves into the genetic underpinnings and risk factors associated with neurodegenerative diseases. It covers the latest research on genetic mutations and variations that contribute to conditions like Alzheimer’s, Parkinson’s, and Huntington’s diseases. Key topics include the role of specific genes, such as APP, PSEN1, and LRRK2, in disease development, and how genetic testing can inform diagnosis and treatment strategies. The track also examines environmental and lifestyle factors that interact with genetic predispositions, influencing disease onset and progression. Attendees will explore emerging research on gene-environment interactions, polygenic risk scores, and the impact of epigenetics on neurodegenerative diseases. By integrating genetic insights with risk factor analysis, this session aims to provide a comprehensive understanding of the biological and environmental factors driving neurodegeneration, paving the way for personalized medicine and targeted interventions.

This session track explores the role of biomarkers and diagnostic tools in advancing dementia research and clinical practice. It highlights cutting-edge biomarkers, including amyloid and tau proteins, and their use in imaging techniques such as PET and MRI for early and accurate dementia diagnosis. The track delves into cerebrospinal fluid (CSF) biomarkers and their relevance in identifying pathological changes. Additionally, it covers emerging diagnostic tools, including genetic testing and advanced neuroimaging methods, that enhance our understanding of dementia's progression. Attendees will gain insights into the integration of these tools in clinical settings, their potential for personalizing treatment, and ongoing research aimed at developing new biomarkers. By focusing on these innovations, the session aims to provide a comprehensive overview of how biomarkers and diagnostic tools are shaping the future of dementia diagnosis and management.

This session track explores the role of biomarkers and diagnostic tools in advancing dementia research and clinical practice. It highlights cutting-edge biomarkers, including amyloid and tau proteins, and their use in imaging techniques such as PET and MRI for early and accurate dementia diagnosis. The track delves into cerebrospinal fluid (CSF) biomarkers and their relevance in identifying pathological changes. Additionally, it covers emerging diagnostic tools, including genetic testing and advanced neuroimaging methods, that enhance our understanding of dementia's progression. Attendees will gain insights into the integration of these tools in clinical settings, their potential for personalizing treatment, and ongoing research aimed at developing new biomarkers. By focusing on these innovations, the session aims to provide a comprehensive overview of how biomarkers and diagnostic tools are shaping the future of dementia diagnosis and management.

This session track explores the role of biomarkers and diagnostic tools in advancing dementia research and clinical practice. It highlights cutting-edge biomarkers, including amyloid and tau proteins, and their use in imaging techniques such as PET and MRI for early and accurate dementia diagnosis. The track delves into cerebrospinal fluid (CSF) biomarkers and their relevance in identifying pathological changes. Additionally, it covers emerging diagnostic tools, including genetic testing and advanced neuroimaging methods, that enhance our understanding of dementia's progression. Attendees will gain insights into the integration of these tools in clinical settings, their potential for personalizing treatment, and ongoing research aimed at developing new biomarkers. By focusing on these innovations, the session aims to provide a comprehensive overview of how biomarkers and diagnostic tools are shaping the future of dementia diagnosis and management.

This session track highlights the latest advancements in Alzheimer's disease drug development, focusing on innovative approaches and emerging therapies. It explores cutting-edge research and novel drug mechanisms targeting key aspects of Alzheimer’s pathology, such as amyloid-beta plaques, tau tangles, and neuroinflammation. Key topics include breakthrough treatments in clinical trials, such as monoclonal antibodies, gene therapies, and small molecules designed to modify disease progression or address symptoms. The track will also cover the use of precision medicine to tailor drug therapies to individual genetic profiles and disease subtypes. Additionally, discussions will address challenges in drug development, including trial design, regulatory hurdles, and the need for biomarkers to assess efficacy. Attendees will gain insights into the evolving landscape of Alzheimer’s drug development, the potential for transformative therapies, and the future directions in research aimed at improving patient outcomes and slowing disease progression

This session track focuses on non-pharmacological interventions designed to improve the quality of life for individuals with dementia. It covers a range of approaches, including cognitive therapies, behavioral strategies, and lifestyle modifications. Key topics include reminiscence therapy, cognitive stimulation, and personalized activity programs aimed at enhancing cognitive function and emotional well-being. The track also explores the role of environmental modifications and structured routines in reducing agitation and improving daily living skills. Attendees will gain insights into evidence-based practices, such as music therapy and art therapy, which can provide emotional support and engagement. Additionally, the session addresses the integration of these interventions into comprehensive care plans and their impact on patient outcomes. By highlighting practical, evidence-driven strategies, this track aims to equip professionals with tools to effectively manage dementia without relying solely on medication

This session track delves into the latest technological advancements in cognitive rehabilitation for individuals with cognitive impairments. It highlights innovative tools and platforms designed to enhance cognitive function and support neuroplasticity. Key topics include virtual reality (VR) environments that provide immersive and interactive cognitive exercises, and computer-based cognitive training programs tailored to individual needs. The track also explores the use of wearable devices for monitoring and improving cognitive performance and the integration of artificial intelligence (AI) in developing personalized rehabilitation protocols. Additionally, attendees will learn about gamification strategies that make cognitive exercises more engaging and motivating. The session will review current research on the efficacy of these technologies and their practical applications in clinical settings. By showcasing cutting-edge solutions, this track aims to provide insights into how emerging technologies are revolutionizing cognitive rehabilitation and offering new opportunities for patient care and recovery.

This session track provides an in-depth look at frontotemporal dementia (FTD), focusing on clinical insights and effective management strategies. It covers the unique presentation of FTD, including behavioral and language deficits, and distinguishes it from other types of dementia. Key discussions will include diagnostic approaches, such as neuroimaging and genetic testing, and how they inform treatment planning. The track also addresses non-pharmacological interventions tailored to FTD, such as behavioral therapies and support for caregivers. Attendees will gain practical knowledge on managing the progression of FTD and improving patient quality of life through personalized care strategies. This session aims to equip healthcare professionals with the tools needed to navigate the complexities of FTD and enhance clinical practice.

This session track explores the pathogenesis and treatment of vascular dementia, a common form of dementia caused by cerebrovascular damage. It covers the underlying mechanisms, including the impact of stroke, a small vessel disease, and other vascular abnormalities on cognitive function. Discussions will focus on how these vascular changes lead to cognitive decline and the clinical presentations of vascular dementia. The track will also review current treatment strategies, including management of vascular risk factors such as hypertension and diabetes, and pharmacological options aimed at improving cognitive function and slowing disease progression. Attendees will gain insights into the latest research and best practices for diagnosing and treating vascular dementia, with an emphasis on multidisciplinary approaches and patient-centered care.

This session track explores a holistic approach to geriatric psychiatry and dementia care, emphasizing the integration of physical, psychological, and social dimensions of health. It covers strategies for addressing the multifaceted needs of elderly patients with dementia, including comprehensive assessments that consider medical conditions, mental health, and social factors. Key topics include the importance of collaborative care teams, involving physicians, psychiatrists, social workers, and caregivers to create personalized care plans. The track will also address non-pharmacological interventions, such as therapeutic activities, environmental modifications, and support systems to enhance patient well-being. Attendees will learn how to implement holistic care models that improve quality of life, promote better management of dementia symptoms, and support the overall health of elderly patients. This session aims to provide practical insights for delivering integrative and compassionate care.

This session track addresses the ethical challenges and considerations in dementia care and research. It explores critical issues such as informed consent, autonomy, and the capacity of individuals with dementia to make decisions about their own care. Discussions will cover how to balance respect for patient autonomy with the need for protective interventions, and strategies for involving patients in decision-making to the extent possible. The track also examines ethical dilemmas in clinical research, including the recruitment of vulnerable populations and the use of experimental treatments. Additionally, it addresses the role of caregivers and family members in ethical decision-making and the importance of maintaining dignity and quality of life for individuals with dementia. By providing a framework for navigating these complex issues, this session aims to equip professionals with the tools to uphold ethical standards in both care and research.

This session track focuses on the critical issue of caregiver burnout in dementia care, offering strategies to support and build resilience among caregivers. It addresses the emotional, physical, and financial challenges faced by caregivers and the signs of burnout, such as fatigue, stress, and emotional exhaustion. Key topics include practical interventions for managing stress, such as self-care techniques, respite care options, and accessing community resources. The track also explores the importance of support networks, including peer support groups and counseling services, in helping caregivers cope with their responsibilities. Attendees will gain insights into creating supportive environments and developing personal resilience strategies to sustain long-term caregiving. This session aims to equip caregivers and professionals with effective tools to prevent burnout and enhance caregiver well-being.

This session track delves into the role of nutrition and lifestyle interventions in promoting brain health and potentially mitigating cognitive decline. It explores evidence-based dietary approaches, such as the Mediterranean and DASH diets, and their impact on brain function and dementia prevention. Key topics include the benefits of specific nutrients, like omega-3 fatty acids, antioxidants, and vitamins, in supporting cognitive health. The track also examines lifestyle factors such as physical exercise, cognitive stimulation, and social engagement, and their synergistic effects on maintaining brain vitality. Discussions will cover practical strategies for incorporating these interventions into daily routines and evaluating their effectiveness. Attendees will gain actionable insights into how dietary choices and lifestyle modifications can contribute to better brain health and potentially reduce the risk of neurodegenerative diseases. This session aims to provide a comprehensive overview of holistic approaches to brain health.

This session track addresses the critical issue of sleep disorders in dementia, focusing on assessment and effective interventions. It covers the prevalence and impact of sleep disturbances, such as insomnia, sleep apnea, and restless legs syndrome, on cognitive function and overall well-being in individuals with dementia. Key discussions include methods for evaluating sleep patterns, including sleep studies and behavioral assessments. The track also explores non-pharmacological interventions, such as cognitive behavioral therapy for insomnia (CBT-I), environmental modifications, and establishing healthy sleep routines. Additionally, pharmacological options will be reviewed, highlighting their benefits and potential risks. Attendees will gain practical strategies for managing sleep disorders, improving sleep quality, and enhancing the quality of life for dementia patients. This session aims to equip healthcare professionals with tools to address and mitigate sleep-related challenges in dementia care.

This session track explores the complex neuropsychiatric symptoms associated with dementia, such as agitation, depression, hallucinations, and delusions. These symptoms present significant challenges in dementia care, affecting both patients and caregivers. The track will cover the latest research on the underlying mechanisms driving these symptoms and their impact on patient outcomes. Discussions will focus on comprehensive assessment strategies to accurately identify and differentiate neuropsychiatric symptoms from other cognitive impairments. Effective management approaches, including pharmacological treatments and non-pharmacological interventions like behavioral therapies and environmental modifications, will be examined. The session will also address the importance of a multidisciplinary approach, incorporating input from psychiatrists, neurologists, and psychologists to create individualized care plans. Attendees will gain practical insights into navigating these challenges and implementing solutions to improve the quality of life for individuals with dementia.

This session track delves into person-centered care models designed to enhance the quality of life for individuals with dementia. It emphasizes tailoring care to each patient’s unique preferences, needs, and values, ensuring that their personal history, interests, and abilities are central to their care plan. Key topics include strategies for involving patients in decision-making, creating supportive environments that promote independence, and implementing individualized activity programs. The track also covers the importance of building strong relationships between caregivers and patients and integrating family input into care planning. Discussions will highlight successful case studies and best practices in applying person-centered principles across various care settings. Attendees will gain practical tools for adopting a person-centered approach, enhancing patient engagement, and improving overall care outcomes for individuals with dementia.

This session track focuses on strategies to enhance the quality of life for individuals living with dementia. It covers a holistic approach to care that integrates medical, psychological, and social aspects to support overall well-being. Key topics include personalized care plans that address individual needs and preferences, and interventions that promote cognitive, physical, and emotional health. Discussions will explore non-pharmacological therapies such as music and art therapy, which can improve mood and engagement, and environmental modifications that create safe, stimulating, and comforting spaces. The track also examines the role of caregiver support, including training and respite options, to prevent burnout and improve care delivery. Additionally, strategies for fostering meaningful social interactions and maintaining autonomy will be highlighted. Attendees will gain practical insights and actionable strategies to create a supportive and enriching environment for individuals with dementia, ultimately enhancing their quality of life.

This session track explores the development and application of multilingual assessment tools in cross-cultural dementia research. It emphasizes the importance of culturally and linguistically appropriate tools for accurately diagnosing and evaluating dementia across diverse populations. Key topics include the challenges of translating and validating cognitive and behavioral assessment instruments to ensure cultural relevance and linguistic accuracy. The track will discuss best practices for adapting existing tools and creating new assessments that consider cultural nuances and variations in dementia presentation. Additionally, it will highlight case studies and research findings on the effectiveness of these tools in improving diagnostic accuracy and research outcomes. Attendees will gain insights into the methodologies for developing and implementing multilingual assessment tools and their impact on advancing cross-cultural dementia research. This session aims to enhance understanding and improve practices in dementia assessment for diverse populations.

This session track delves into the transformative role of music and art therapy in dementia care. It highlights how these creative therapies can enhance emotional well-being, cognitive function, and overall quality of life for individuals with dementia. Key discussions will cover the mechanisms through which music and art therapy influence brain function, including the reduction of anxiety, depression, and agitation, and the promotion of social engagement and self-expression. The track will explore evidence-based practices and successful case studies that demonstrate the efficacy of these therapies in various settings. Attendees will learn about practical implementation strategies, including selecting appropriate activities, integrating therapy into daily routines, and measuring outcomes. The session aims to provide actionable insights and tools for incorporating music and art therapy into comprehensive dementia care plans, ultimately enriching the lives of patients and enhancing their care experience.

This session track explores the critical role of neuroinflammation in the development and progression of Alzheimer’s disease. It examines how inflammatory processes contribute to neurodegeneration, including the activation of microglia and astrocytes, and the release of pro-inflammatory cytokines. Key topics include the relationship between neuroinflammation and amyloid-beta plaques, tau tangles, and synaptic loss. The track will also cover recent research on how neuroinflammation pathways can be targeted for therapeutic intervention, including novel anti-inflammatory drugs and lifestyle modifications aimed at reducing inflammation. Additionally, discussions will address the impact of systemic inflammation and how chronic diseases or infections may exacerbate neuroinflammation responses in Alzheimer’s patients. Attendees will gain insights into the mechanisms linking neuroinflammation with Alzheimer’s pathology and explore potential strategies for mitigating its effects, offering a comprehensive overview of how inflammation influences disease progression and treatment prospects

This session track delves into the genetic underpinnings of Frontotemporal Lobar Degeneration (FTLD), a group of disorders characterized by progressive damage to the frontal and temporal lobes of the brain. It explores the key genetic mutations associated with FTLD, including those in the MAPT, GRN, and C9orf72 genes, which are linked to tauopathies, tau-negative frontotemporal dementia, and motor neuron disease, respectively. The track will cover how these genetic factors influence disease onset, progression, and clinical presentation. Discussions will include advances in genetic testing and their role in diagnosis and personalized treatment strategies. Additionally, the session will address ongoing research into gene-environment interactions and potential therapeutic targets. Attendees will gain a comprehensive understanding of the genetic basis of FTLD, its impact on disease mechanisms, and implications for future research and clinical practice.

This session track explores cutting-edge assistive technologies designed to enhance the lives of individuals with dementia. It highlights the latest advancements in tools and devices that support daily living, safety, and communication. Key topics include smart home systems that automate and simplify tasks, wearable devices that monitor health and location, and cognitive aids such as digital reminders and personalized apps. The track will also cover innovations in virtual reality (VR) and augmented reality (AR) used for cognitive stimulation and therapeutic interventions. Additionally, discussions will focus on the integration of artificial intelligence (AI) to tailor assistive technology to individual needs and preferences. Attendees will gain insights into practical applications of these technologies, their benefits and limitations, and how they can be implemented to improve patient autonomy and quality of life. This session aims to showcase how technological advancements are shaping the future of dementia care

This session track examines the significant impact of social isolation on cognitive decline, particularly in older adults and individuals with dementia. It explores how prolonged social isolation can exacerbate cognitive deterioration by affecting mental health, stress levels, and overall brain function. Key topics include the mechanisms linking social isolation to increased risk of cognitive impairment, such as reduced cognitive stimulation, loneliness, and depression. The track will review research on the effects of social engagement and support networks in mitigating cognitive decline and enhancing brain health. Discussions will also cover practical strategies for reducing social isolation, including community programs, technology-based solutions for virtual social interactions, and caregiver support. Attendees will gain insights into the importance of social connections for cognitive health and explore interventions to promote social engagement and prevent the adverse effects of isolation on cognitive function.

This session track focuses on providing comprehensive palliative care for individuals with advanced dementia, emphasizing the importance of addressing end-of-life needs with compassion and expertise. It explores strategies for managing symptoms such as pain, agitation, and difficulty with daily activities, ensuring comfort and dignity during the final stages of life. Key topics include advanced care planning, communication techniques with patients and families, and creating a supportive environment that honors the individual's preferences and values. The track will discuss the role of interdisciplinary teams in delivering holistic care and the integration of palliative care principles into dementia management. Additionally, it will cover ethical considerations and support for caregivers facing end-of-life challenges. Attendees will gain practical insights into effective palliative care approaches, aiming to improve the quality of life and provide compassionate support for patients and their families during advanced dementia.

This session track highlights the significance of collaborative research initiatives in advancing the search for a dementia cure. It explores the benefits of interdisciplinary and cross-institutional partnerships that bring together researchers, clinicians, and industry experts to tackle the complex challenges of dementia. Key topics include large-scale collaborative studies, such as international consortia and public-private partnerships, which focus on pooling resources, sharing data, and integrating diverse expertise to accelerate discoveries. The track will also address innovative research approaches, including multi-center clinical trials, data sharing platforms, and collaborative frameworks that foster breakthroughs in understanding disease mechanisms and developing novel treatments. Discussions will emphasize successful case studies, funding opportunities, and strategies for overcoming barriers to collaboration. Attendees will gain insights into how collaborative research efforts are crucial for advancing toward effective dementia therapies and ultimately finding a cure.

This session track focuses on the power of collaborative research initiatives in the quest for a dementia cure. It highlights how interdisciplinary partnerships—bringing together researchers, clinicians, and industry leaders—enhance our ability to tackle the complexities of dementia. Key discussions will cover large-scale collaborative projects, including international consortia and public-private partnerships, which facilitate data sharing, resource pooling, and innovative research strategies. The track will also address the role of multi-center clinical trials and joint research platforms in accelerating progress. Attendees will explore successful examples of collaboration, funding opportunities, and strategies to overcome challenges in working together. By showcasing the impact of these collaborative efforts, the session aims to illustrate how teamwork and shared expertise are essential in advancing towards effective dementia treatments and ultimately finding a cure.

This session track examines the neurocognitive effects of long-term medication use in older adults. It explores how chronic use of various medications, including anticholinergics, benzodiazepines, and antidepressants, can impact cognitive function and contribute to conditions like cognitive decline and dementia. Key topics include the mechanisms through which these medications affect brain health, potential interactions with other drugs, and the balance between therapeutic benefits and cognitive risks. The track will also review strategies for monitoring and managing these effects, such as regular cognitive assessments and adjusting medication regimens. Discussions will highlight case studies and research findings on medication-related cognitive impairment and the importance of personalized medication management. Attendees will gain insights into how to mitigate potential cognitive risks associated with long-term medication use, ensuring safer and more effective treatment approaches for senior patients

This session track explores the concept of precision medicine in dementia care, focusing on how personalized approaches can enhance treatment effectiveness. It covers the integration of genetic, environmental, and lifestyle factors to tailor interventions for individual patients. Key topics include the use of genetic biomarkers to identify specific disease subtypes and predict treatment responses, as well as the role of advanced imaging techniques in personalizing care plans. The track will also discuss the application of machine learning and data analytics to refine treatment strategies and predict disease progression. Additionally, it will address the challenges and opportunities in implementing precision medicine, including ethical considerations and the need for multidisciplinary collaboration. Attendees will gain insights into how precision medicine can transform dementia care by providing targeted treatments, optimizing therapeutic outcomes, and improving patient quality of life through individualized care plans.

This session track investigates the emerging role of the microbiome in cognitive health and neurodegenerative diseases. It explores how the gut microbiota influences brain function through the gut-brain axis, impacting inflammation, neurotransmitter production, and overall cognitive health. Key topics include the connection between microbiome composition and cognitive conditions such as Alzheimer’s and Parkinson’s diseases. The track will discuss research on how microbiome imbalances may contribute to neuroinflammation and cognitive decline, and examine potential interventions such as probiotics, prebiotics, and dietary modifications to support a healthy microbiome. Discussions will also cover the implications of microbiome research for developing novel therapeutic strategies and improving patient outcomes. Attendees will gain insights into how understanding and modulating the microbiome could lead to innovative approaches in preventing and treating cognitive disorders, enhancing both research and clinical practices in cognitive health.

This session track focuses on creating dementia-friendly communities through thoughtful design and proactive outreach. It highlights the principles of designing environments that support the needs of individuals with dementia, including clear signage, safe and navigable spaces, and sensory-friendly features. Key topics include architectural modifications that enhance accessibility and reduce confusion, such as contrast in flooring, well-lit areas, and quiet zones. The track will also cover community outreach strategies, including training programs for local businesses and organizations to foster understanding and support for people with dementia. Discussions will explore successful case studies and best practices for integrating dementia-friendly features into public spaces and residential areas. Attendees will gain practical insights into how community design and outreach can improve daily living for individuals with dementia, promote inclusion, and enhance overall quality of life.

This session track addresses the crucial issue of reshaping public perception and reducing stigma associated with dementia. It explores strategies to increase awareness, understanding, and empathy towards individuals living with dementia. Key topics include public education campaigns, media representation, and community engagement initiatives designed to challenge stereotypes and misconceptions. The track will also discuss the role of advocacy groups and partnerships in promoting a positive image of dementia and supporting affected individuals and their families. Emphasis will be placed on the importance of inclusive language and the impact of storytelling in changing attitudes. Additionally, the session will highlight successful case studies and evidence-based approaches to fostering a more supportive and compassionate societal attitude towards dementia. Attendees will gain insights into effective methods for advocating for change and creating a more inclusive environment that respects and values individuals with dementia.

This session track delves into the significance of longitudinal studies in understanding cognitive aging and assessing dementia risk. It explores how extended, multi-year research initiatives track cognitive changes over time to identify early biomarkers and risk factors for dementia. Key topics include the methodologies used in these studies, such as repeated cognitive assessments, imaging techniques, and genetic analyses, to uncover patterns and predictors of cognitive decline. The track will also discuss findings on how lifestyle factors, genetics, and environmental influences contribute to dementia risk and cognitive aging. Emphasis will be placed on the implications of these studies for early intervention and prevention strategies. Attendees will gain insights into the design and outcomes of notable longitudinal studies, the challenges in maintaining long-term research, and how these studies contribute to developing targeted approaches for managing and mitigating dementia risk

This session track focuses on essential legal and financial planning considerations for individuals with dementia. It covers the importance of early and proactive planning to address legal and financial issues that arise as cognitive decline progresses. Key topics include establishing power of attorney, setting up advance directives, and creating living wills to ensure that personal wishes are respected and decision-making authority is clearly defined. The track will also address strategies for managing finances, including budgeting, safeguarding assets, and accessing benefits and insurance options. Discussions will highlight the role of legal professionals in guiding families through these processes and the importance of involving individuals with dementia in planning while they are still able to contribute. Attendees will gain practical insights into developing comprehensive legal and financial plans that provide protection and support for individuals with dementia and their families, ensuring their needs are met with dignity.

This session track explores the beneficial effects of exercise on cognitive function in aging individuals. It delves into how physical activity influences brain health, potentially mitigating age-related cognitive decline and reducing the risk of neurodegenerative diseases. Key topics include the mechanisms through which exercise promotes neuroplasticity, improves blood flow to the brain, and enhances cognitive processes such as memory and executive function. The track will review evidence from clinical trials and observational studies on different types of exercise, including aerobic, resistance, and flexibility training, and their specific impacts on cognitive health. Additionally, discussions will cover practical recommendations for integrating exercise into daily routines and creating personalized fitness plans for older adults. Attendees will gain insights into the role of physical activity in preserving cognitive function and strategies for encouraging and maintaining an active lifestyle in aging populations.

This session track explores the innovative use of virtual reality (VR) in dementia therapy and engagement. It examines how VR technology can create immersive, interactive environments that support cognitive stimulation, emotional well-being, and social interaction for individuals with dementia. Key topics include the development of VR programs tailored to specific therapeutic goals, such as reminiscence therapy, cognitive exercises, and relaxation techniques. The track will discuss how VR can simulate real-life experiences and activities, offering a safe and engaging way to improve quality of life and reduce agitation. Attendees will learn about successful case studies and research findings that demonstrate the efficacy of VR interventions in enhancing cognitive function and social participation. Additionally, discussions will cover practical considerations for implementing VR in clinical and home settings, including accessibility, user-friendliness, and integration with existing care plans.